polyglutamine

ataxin 1 ; Homo sapiens







108 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35499073 Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1. 2022 May 2 5
2 31381977 5'UTR-mediated regulation of Ataxin-1 expression. 2020 Feb 3
3 32005838 Nuclear bodies formed by polyQ-ataxin-1 protein are liquid RNA/protein droplets with tunable dynamics. 2020 Jan 31 2
4 32145456 Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery. 2020 May 6
5 32581673 The Mechanisms of Nuclear Proteotoxicity in Polyglutamine Spinocerebellar Ataxias. 2020 1
6 32581696 Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion. 2020 1
7 32671744 Autophagy and Polyglutamine Disease. 2020 1
8 32873576 UTteR control through miRs: fine-tuning ATXN1 levels to prevent ataxia. 2020 Sep 1 1
9 32954321 ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. 2020 3
10 32962458 Polyglutamine spinocerebellar ataxias: emerging therapeutic targets. 2020 Nov 2
11 32992839 Dynamics of a Protein Interaction Network Associated to the Aggregation of polyQ-Expanded Ataxin-1. 2020 Sep 25 1
12 30707359 EvoPPI 1.0: a Web Platform for Within- and Between-Species Multiple Interactome Comparisons and Application to Nine PolyQ Proteins Determining Neurodegenerative Diseases. 2019 Mar 2
13 31655597 ATXN1 N-terminal region explains the binding differences of wild-type and expanded forms. 2019 Oct 26 8
14 29274668 ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis. 2018 Apr 3
15 29533923 Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1. 2018 Jun 1 3
16 30108484 PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption. 2018 5
17 30473770 Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view. 2018 2
18 27306906 Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1. 2017 Apr 4
19 29212253 Ataxin-1 is involved in tumorigenesis of cervical cancer cells via the EGFR-RAS-MAPK signaling pathway. 2017 Nov 7 2
20 26748090 Impaired mTORC1-Dependent Expression of Homer-3 Influences SCA1 Pathophysiology. 2016 Jan 6 1
21 26879337 Characterization of the AXH domain of Ataxin-1 using enhanced sampling and functional mode analysis. 2016 May 1
22 27058144 BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1. 2016 Jul 7 12
23 27658206 Polyglutamine Tract Expansion Increases S-Nitrosylation of Huntingtin and Ataxin-1. 2016 1
24 27686464 RNAi prevents and reverses phenotypes induced by mutant human ataxin-1. 2016 Nov 1
25 27895927 Expansion, mosaicism and interruption: mechanisms of the CAG repeat mutation in spinocerebellar ataxia type 1. 2016 7
26 25641559 A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation. 2015 May 4
27 27168726 Stabilization and Degradation Mechanisms of Cytoplasmic Ataxin-1. 2015 5
28 23853075 Chemical shift assignment of the ataxin-1 AXH domain in complex with a CIC ligand peptide. 2014 Oct 1
29 24711972 Mapping the self-association domains of ataxin-1: identification of novel non overlapping motifs. 2014 1
30 24741770 A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases. 2014 Jan-Mar 1
31 24858692 Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17. 2014 Jul 11 7
32 25131594 Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures. 2014 6
33 25309920 From pathways to targets: understanding the mechanisms behind polyglutamine disease. 2014 1
34 23528090 Self-assembly and conformational heterogeneity of the AXH domain of ataxin-1: an unusual example of a chameleon fold. 2013 Mar 19 1
35 23754227 Regulation of ataxin-1 phosphorylation and its impact on biology. 2013 1
36 23760502 An out-of-frame overlapping reading frame in the ataxin-1 coding sequence encodes a novel ataxin-1 interacting protein. 2013 Jul 26 2
37 23877406 New hope for therapy in neurodegenerative diseases. 2013 Oct 2
38 23935513 The role of interruptions in polyQ in the pathology of SCA1. 2013 2
39 24225362 Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. 2013 Nov 13 1
40 21827903 Spinocerebellar ataxia type 1. 2012 2
41 21964520 Comparative genetics of the poly-Q tract of ataxin-1 and its binding protein PQBP-1. 2012 Apr 1
42 22309224 Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights. 2012 Dec 2
43 22491195 Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. 2012 Apr 1
44 22511762 Ataxin-1 poly(Q)-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1. 2012 Jul 6 1
45 22531670 SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis. 2012 Dec 8
46 22831947 Inherited polyglutamine spinocerebellar ataxias in South Africa. 2012 Jun 14 1
47 22916034 Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1. 2012 1
48 23022625 Comparative aspects of polyglutamine binding domain in PQBP-1 among Vertebrata. 2012 Dec 15 1
49 23197749 Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. 2012 Dec 11 3
50 20451302 Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. 2011 Dec 1